Michael A. Letavic

3.3k total citations
69 papers, 2.3k citations indexed

About

Michael A. Letavic is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Michael A. Letavic has authored 69 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Organic Chemistry and 21 papers in Physiology. Recurrent topics in Michael A. Letavic's work include Adenosine and Purinergic Signaling (21 papers), Mast cells and histamine (15 papers) and Chemical Synthesis and Analysis (10 papers). Michael A. Letavic is often cited by papers focused on Adenosine and Purinergic Signaling (21 papers), Mast cells and histamine (15 papers) and Chemical Synthesis and Analysis (10 papers). Michael A. Letavic collaborates with scholars based in United States, Belgium and Ireland. Michael A. Letavic's co-authors include Anindya Bhattacharya, Nicholas I. Carruthers, Brian Lord, Thomas A. Engler, Timothy W. Lovenberg, Pascal Bonaventure, Leah Aluisio, E. J. Corey, Jayachandra P. Reddy and Jason C. Rech and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Michael A. Letavic

68 papers receiving 2.3k citations

Peers

Michael A. Letavic
Nicholas I. Carruthers United States
Björn Kull Sweden
Jean E. Lachowicz United States
Dilip K. Tosh United States
Marlon Cowart United States
Matthew A. Sills United States
Barbara Costa Italy
Antoni Cortés Spain
Mark J. Wall United Kingdom
Christopher J. Langmead Australia
Nicholas I. Carruthers United States
Michael A. Letavic
Citations per year, relative to Michael A. Letavic Michael A. Letavic (= 1×) peers Nicholas I. Carruthers

Countries citing papers authored by Michael A. Letavic

Since Specialization
Citations

This map shows the geographic impact of Michael A. Letavic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Letavic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Letavic more than expected).

Fields of papers citing papers by Michael A. Letavic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Letavic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Letavic. The network helps show where Michael A. Letavic may publish in the future.

Co-authorship network of co-authors of Michael A. Letavic

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Letavic. A scholar is included among the top collaborators of Michael A. Letavic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Letavic. Michael A. Letavic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gelin, Christine F., Heather Coate, Brian Lord, et al.. (2023). Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric Modulators. Journal of Medicinal Chemistry. 66(4). 2877–2892. 3 indexed citations
3.
Berdyyeva, Tamara, Chunfang Xia, Natalie Taylor, et al.. (2019). PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation. Molecular Imaging and Biology. 21(5). 871–878. 44 indexed citations
4.
Yun, Sujin, Michelle Wennerholm, Jonathan Shelton, et al.. (2017). Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in Mice. Frontiers in Behavioral Neuroscience. 11. 83–83. 24 indexed citations
5.
Jimenez‐Pacheco, Alba, Miguel Díaz‐Hernández, Marina Arribas-Blázquez, et al.. (2016). Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy. Journal of Neuroscience. 36(22). 5920–5932. 131 indexed citations
6.
Alcázar, Jesús, Michael K. Ameriks, Hong Ao, et al.. (2015). Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. 25(16). 3157–3163. 30 indexed citations
7.
Lord, Brian, Michael K. Ameriks, Qi Wang, et al.. (2015). A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334. European Journal of Pharmacology. 765. 551–559. 45 indexed citations
8.
Lord, Brian, Leah Aluisio, James R. Shoblock, et al.. (2014). Pharmacology of a Novel Central Nervous System–Penetrant P2X7 Antagonist JNJ-42253432. Journal of Pharmacology and Experimental Therapeutics. 351(3). 628–641. 65 indexed citations
9.
Tran, Da‐Thao, Pascal Bonaventure, Michael D. Hack, et al.. (2011). Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology. 667(1-3). 120–128. 25 indexed citations
10.
Stocking, Emily M., Michael A. Letavic, Pascal Bonaventure, & Nicholas I. Carruthers. (2010). Exploration of Structure-Activity Relationships for Dual Serotonin Transporter Reuptake Inhibitors-Histamine H3 Receptor Antagonists. Current Topics in Medicinal Chemistry. 10(5). 596–616. 6 indexed citations
11.
Letavic, Michael A., Emily M. Stocking, Ann Barbier, et al.. (2007). Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4799–4803. 9 indexed citations
12.
Bembenek, Scott D., John M. Keith, Michael A. Letavic, et al.. (2007). Lead identification of acetylcholinesterase inhibitors–histamine H3 receptor antagonists from molecular modeling. Bioorganic & Medicinal Chemistry. 16(6). 2968–2973. 48 indexed citations
13.
Ly, Kiev S., Michael A. Letavic, John M. Keith, et al.. (2007). Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 39–43. 19 indexed citations
14.
Keith, John M., Michael A. Letavic, Kiev S. Ly, et al.. (2006). Dual serotonin transporter/histamine H3 ligands: Optimization of the H3 pharmacophore. Bioorganic & Medicinal Chemistry Letters. 17(3). 702–706.
15.
Letavic, Michael A., Ann Barbier, Curt A. Dvorak, & Nicholas I. Carruthers. (2006). 5 Recent Medicinal Chemistry of the Histamine H3 Receptor. Progress in medicinal chemistry. 44. 181–206. 36 indexed citations
16.
Dombroski, Mark A., Michael A. Letavic, Kim F. McClure, et al.. (2004). Benzimidazolone p38 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(4). 919–923. 22 indexed citations
17.
Bronk, Brian S., Michael A. Letavic, D. M. George, et al.. (2003). Synthesis, stereochemical assignment and biological activity of a novel series of C-4″ modified aza-Macrolides. Bioorganic & Medicinal Chemistry Letters. 13(12). 1955–1958. 5 indexed citations
18.
Letavic, Michael A., Thomas J. Carty, Joel R. Hardink, et al.. (2003). Synthesis and biological activity of piperazine-Based dual MMP-13 and TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(19). 3243–3246. 29 indexed citations
19.
Letavic, Michael A., Brian S. Bronk, Jeffrey Casavant, et al.. (2002). Synthesis and Activity of a Novel Class of Tribasic Macrocyclic Antibiotics: The Triamilides. Bioorganic & Medicinal Chemistry Letters. 12(19). 2771–2774. 39 indexed citations
20.
Letavic, Michael A., et al.. (1991). Competitive binding assays for high-affinity binders in the presence of endogenous ligands: Application to biotin-binding proteins. Analytical Biochemistry. 192(2). 392–397. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicholas I. Carruthers Breakdown of academic impact, for papers by Björn Kull Breakdown of academic impact, for papers by Jean E. Lachowicz Breakdown of academic impact, for papers by Dilip K. Tosh Breakdown of academic impact, for papers by Marlon Cowart Breakdown of academic impact, for papers by Matthew A. Sills Breakdown of academic impact, for papers by Barbara Costa Breakdown of academic impact, for papers by Antoni Cortés Breakdown of academic impact, for papers by Mark J. Wall Breakdown of academic impact, for papers by Christopher J. Langmead
Rankless by CCL
2026